IMNM
$16.47-5.34%
Immunome Inc.Stock · HealthcareRussell 2000 0.07%Nasdaq Composite 0.006%Russell 3000 0.003%US Stock Market 0.003%
Immunome Inc. total returns by year (including dividends)
As of market close, Oct 16, 2026
Immunome Inc. total returns by year (2021–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $21.48 | $16.47 | 0.0% | -23.3% | |
| 2025 | $10.62 | $21.48 | 0.0% | +102.3% | |
| 2024 | $10.70 | $10.62 | 0.0% | -0.7% | |
| 2023 | $2.21 | $10.70 | 0.0% | +384.2% | |
| 2022 | $12.96 | $2.21 | 0.0% | -82.9% | |
| 2021 | $9.68 | $12.96 | 0.0% | +33.9% |
- Annualized
- +6.4%
- 2021–2026
- Average year
- +87.3%
- 5 full years
- Best year
- +384.2%
- 2023
- Worst year
- -82.9%
- 2022
- Positive years
- 3/5
- 60% up
Annualized (CAGR)
+6.4%
2021–2026
Average year
+87.3%
5 full years
Best year
+384.2%
2023
Worst year
-82.9%
2022
Positive years
3/5
60% up
Total return by period#
Annual
-200%0%200%
2021+34%'21
2022-83%'22
2023+384%'23
2024-0.75%'24
2025+102%'25
2026-23%'26
Methodology#
Total returns, dividends reinvested, measured on IMNM. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Immunome Inc.'s average annual return?
- Since 2021, Immunome Inc. (IMNM) has returned about 6.4% a year (the compound annual growth rate) and an average calendar-year return of 87.3%.
- What were Immunome Inc.'s best and worst years?
- Over 2021–2026, the best year was 2023 (+384.2%) and the worst was 2022 (-82.9%).
- How often is Immunome Inc. up in a year?
- 3 of the 5 full years since 2021 were positive — about 60% of the time.
More on Immunome Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100